Victoria Shapiro
vshapiro@susandavis.com
(202) 414-0774
Washington, D.C. (January 17, 2012) — LUNGevity Foundation, the nation’s largest lung cancer nonprofit, is gearing up for an aggressive year in fighting the nation’s number one cancer killer, lung cancer. As a thought leader and community hub, LUNGevity is providing critical resources to the lung community through its webinar series in partnership with GRACE. The first webinar of 2012, “2011 Highlights in Lung Cancer Screening and Targeted Therapies” will take place Thursday, January 19th, at 7 pm EST, 4 pm PST. The webinar will address the most important developments in the field of lung cancer from 2011, with a special focus on new screening developments and improved use of targeted therapies for the treatment of the disease.
Researchers, lung cancer survivors and their loved ones, as well as interested reporters and others engaged with the lung cancer community are encouraged to participate in the free webinar.
Dr. Jared Weiss, associate professor in the Department of Medical Oncology at the Lineberger Cancer Center at the University of North Carolina at Chapel Hill, will present his view of the key highlights of lung cancer research developments from the last year. His presentation will be followed by a 15 minute question and answer session with the live webinar audience.
Weiss also serves as director of the Lung Cancer and Head/Neck Cancer sections of GRACE, a nonprofitthat seeks to improve medical care for cancer patients by democratizing access to cutting edge information on optimal cancer management.
To register, interested participants should visit the “Ask the Experts” section of LUNGevity’s website:www.lungevity.org. For those unable to attend the live presentation, it will be accessible as a free podcast on LUNGevity’s website at a later date. Stay tuned to the LUNGevity website for future scheduled webinars.
LUNGevity has the largest grants award program for lung cancer research among lung cancer nonprofit organizations in the United States. In 2011 alone, it awarded $2 million to fund nine of the most promising lung cancer research proposals in the areas of early detection and targeted therapeutics. Through the support of critical research, as well as providing information, resources and a community to patients and caregivers, LUNGevity is creating and sharing hope for cures, treatments and enhanced quality of life for lung cancer patients.
About LUNGevity Foundation
The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.
In order to accomplish our mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer. LUNGevity also supports the largest national grassroots lung cancer network, as well as the largest online support community for those affected by lung cancer.
The organization was recently awarded the coveted four-star charity ranking by Charity Navigator, American’s premier charity evaluator based on LUNGevity’s sound fiscal management and commitment to accountability and transparency.
LUNGevity seeks to inspire the nation to commit to ending lung cancer.
For more information, please visit www.lungevity.org.